Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Factors associated with COVID-19 susceptibility and severity in patients with multiple sclerosis: A systematic review

View ORCID ProfileMahdi Barzegar, Sara bagherieh, Shakiba Houshi, Mozhgan Sadat Hashemi, Ghasem Pishgahi, Alireza Afshari-Safavi, Omid Mirmosayyeb, Vahid Shaygannejad, Aram Zabeti
doi: https://doi.org/10.1101/2021.06.11.21258765
Mahdi Barzegar
1Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
2Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mahdi Barzegar
Sara bagherieh
1Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shakiba Houshi
1Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mozhgan Sadat Hashemi
3Students’ Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ghasem Pishgahi
3Students’ Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alireza Afshari-Safavi
4Department of Biostatistics and Epidemiology, Faculty of Health, North Khorasan University of Medical Sciences, Bojnurd, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Omid Mirmosayyeb
1Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
2Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: v.shaygannejad@gmail.com shaygannejad@med.mui.ac.ir omid.mirmosayyeb@gmail.com
Vahid Shaygannejad
1Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
2Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: v.shaygannejad@gmail.com shaygannejad@med.mui.ac.ir omid.mirmosayyeb@gmail.com
Aram Zabeti
5Department of Neurology and Rehabilitation Medicine, University of Cincinnati, Cincinnati, OH, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background We conducted this systematic review to identify factors associated with coronavirus disease (COVID-19) susceptibility and outcomes among people with multiple sclerosis (MS).

Methods Available studies from PubMed, Scopus, EMBASE, Web of Science, and gray literature including reference list and conference abstracts were searched from December 1, 2019, through April 12, 2021. We included cross-sectional, case-control, and cohort studies that reported risk factors of contracting COVID-19 or its outcome in patients with MS on univariate or multivariate regression analyses.

Results Out of the initial 2719 records and 1553 conference abstracts, a total of 20 studies were included. Factors associated with COVID-19 susceptibility were reported in 11 studies and risk factors for infection outcomes were discussed in 10. History of contact with an infected is strongly suggested as a risk factor for COVID-19 susceptibility. Other factors that could be associated with contracting infection are younger age, relapsing course, and anti-CD20 agents. The evidence suggests that increasing age, greater MS severity, treatment with anti-CD20 agents, previous use of corticosteroids, and specific comorbidities (obesity and coronary artery disease) could be independently associated with worse infection outcomes. Male sex is likely to be a risk factor for more severe disease. The black or African American race was reported as a possible risk factor.

Conclusion Due to a paucity of research and methodological issues, no risk factors for COVID-19 susceptibility and outcomes neither be confirmed nor excluded. Further large studies are needed to address factors associated with COVID-19 susceptibility and severity.

Competing Interest Statement

Aram Zabeti reports compensation for lectures given for Biogen, Genzyme, Novartis, Genentech and ACORDA. Others report no conflict of interest.

Funding Statement

No funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This is systematic review. It does not need ethical approval

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data available on request from the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted June 15, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Factors associated with COVID-19 susceptibility and severity in patients with multiple sclerosis: A systematic review
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Factors associated with COVID-19 susceptibility and severity in patients with multiple sclerosis: A systematic review
Mahdi Barzegar, Sara bagherieh, Shakiba Houshi, Mozhgan Sadat Hashemi, Ghasem Pishgahi, Alireza Afshari-Safavi, Omid Mirmosayyeb, Vahid Shaygannejad, Aram Zabeti
medRxiv 2021.06.11.21258765; doi: https://doi.org/10.1101/2021.06.11.21258765
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Factors associated with COVID-19 susceptibility and severity in patients with multiple sclerosis: A systematic review
Mahdi Barzegar, Sara bagherieh, Shakiba Houshi, Mozhgan Sadat Hashemi, Ghasem Pishgahi, Alireza Afshari-Safavi, Omid Mirmosayyeb, Vahid Shaygannejad, Aram Zabeti
medRxiv 2021.06.11.21258765; doi: https://doi.org/10.1101/2021.06.11.21258765

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neurology
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (577)
  • Anesthesia (139)
  • Cardiovascular Medicine (1942)
  • Dentistry and Oral Medicine (252)
  • Dermatology (183)
  • Emergency Medicine (331)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (697)
  • Epidemiology (11086)
  • Forensic Medicine (8)
  • Gastroenterology (619)
  • Genetic and Genomic Medicine (3156)
  • Geriatric Medicine (307)
  • Health Economics (560)
  • Health Informatics (2037)
  • Health Policy (861)
  • Health Systems and Quality Improvement (781)
  • Hematology (309)
  • HIV/AIDS (682)
  • Infectious Diseases (except HIV/AIDS) (12702)
  • Intensive Care and Critical Care Medicine (707)
  • Medical Education (317)
  • Medical Ethics (92)
  • Nephrology (334)
  • Neurology (2977)
  • Nursing (162)
  • Nutrition (461)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1548)
  • Ophthalmology (474)
  • Orthopedics (185)
  • Otolaryngology (265)
  • Pain Medicine (201)
  • Palliative Medicine (57)
  • Pathology (402)
  • Pediatrics (909)
  • Pharmacology and Therapeutics (381)
  • Primary Care Research (354)
  • Psychiatry and Clinical Psychology (2774)
  • Public and Global Health (5583)
  • Radiology and Imaging (1090)
  • Rehabilitation Medicine and Physical Therapy (630)
  • Respiratory Medicine (755)
  • Rheumatology (338)
  • Sexual and Reproductive Health (311)
  • Sports Medicine (287)
  • Surgery (342)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (131)